Tissuepathology.com

Indica Labs: Learn about Indica Labs’ ability to deliver AI-driven CDx

Diagnexia is attending The Executive War College Conference 2026! Pathology labs are under growing pressure with staffing gaps, costly locums, and rising caseloads putting diagnostic quality and turnaround times at risk. Join Diagnexia in New Orleans, LA April 28-29 to see how we deliver CLIA-compliant, subspecialty pathology coverage on demand. Consistent, high-quality reads Seamless support for staffing gaps & PTO No contracts. No IT lift.

Proscia: Implementing Concentriq to anchor a connected network and expand access to high-quality diagnoses LEEUWARDEN, Netherlands and PHILADELPHIA — April 14, 2026 — Pathologie Friesland, a regional pathology laboratory serving the Dutch province of Friesland, is moving to Concentriq® from Proscia® to position its network for future growth.

NEWTON, Mass.–(BUSINESS WIRE)–4D Path, a company dedicated to personalizing cancer care through a novel, physics-informed approach to predicting tumor response to therapy, today announced a collaboration with Daiichi Sankyo (TSE: 4568) to develop next-generation predictive biomarkers in an antibody drug conjugate (ADC) clinical development program.

From the Tribun Health blog: Discover CaloPix Connect, Tribun Health’s open API to seamlessly integrate AI into pathology workflows, without disruption or added complexity. Artificial Intelligence is rapidly transforming pathology. Automated metastasis detection, biomarker quantification, scoring assistance, therapeutic prediction—the use cases are multiplying and paving the way for faster, more precise diagnoses.

From the Proscia blog: How Proscia’s Concentriq platform transforms fragmented workflows into a scalable, AI-ready engine for precision medicine growth. Precision medicine is the frontier of modern oncology. Precision medicine companies are processing unprecedented molecular volumes, serving distributed health system networks, and racing to deploy AI-driven diagnostics that can meaningfully improve patient outcomes.

bioAffinity Technologies: Invitation-only conference focuses on the evolving landscape of lung cancer risk and early detection when the disease is most treatable bioAffinity Technologies Chief Medical Officer Gordon Downie, MD, PhD, to participate in panel on lung nodule management SAN ANTONIO, TX – April 7, 2026 – bioAffinity Technologies, Inc.

BOSTON and COLUMBIA, Md., April 07, 2026 (GLOBE NEWSWIRE) — PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to deploy PathAI’s AISight® Dx1 Digital Pathology Platform and various AI algorithm products across the multi-site network.

Voicebrook and Corista: The Voicebrook-Corista integration enables hands-free slide navigation, AI interaction, and streamlined reporting for more efficient, connected pathology workflows. Roslyn Heights, NY, March 23, 2026 –(PR.com)– Voicebrook, the leader in speech-enabled reporting and workflow automation solutions for pathology, today announced a new integration partnership with Corista, a leader in digital pathology and image management.

Pictor Labs: AI-Powered Virtual Staining Can Now Run Directly Within Pathology Labs First-to-market, production-ready On-Prem deployment system enables secure, high-speed virtual staining without transmitting data to external cloud infrastructure Visit Pictor Labs at Booth #749 for a hands-on demonstration , /PRNewswire/ — Pictor Labs, the virtual staining company, enabling digital pathology adoption worldwide, today announced the launch of its On-Prem deployment system, a dedicated hardware...